Recurrent Pancreatic Carcinoma Completed Phase 1 Trials for Afatinib (DB08916)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

IndicationStatusPhase
DBCOND0043478 (Recurrent Pancreatic Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02451553Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary CancerTreatment